Search Browse Earnings

Adagene Inc.

Nasdaq:ADAG

Pharmaceutical Preparations·JIANGSU, F4

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$9.3M

-8.7% YoY

FY 2024

Adj. EBITDA

-$82.8M

-890.7% margin

FY 2024

Net Income

-$80.0M

-860.6% margin

FY 2024

EPS (Diluted)

-$1.48

FY 2024

Stock Price

$3.99

-3.4%

2026-03-16

52W Range

$1.30 – $4.58

P/E Ratio

-2.7x

Market Cap

$235.0M

Cash

$109.9M

FY 2024

Total Debt

$21.9M

FY 2024

Net Cash

$88.0M

FY 2024

Enterprise Value

$147.0M

Debt / EBITDA

1.1x

FY 2024

EV / EBITDA

-1.8x

Employees

—